Kallyope rebrands with $94M Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T W Thu F 1 October, 2026

The entire healthcare ecosystem is more Silicon Valley-ified than ever before. What tech has actually changed? Is biopharma behind? Find out, join us for Health Tech day.

news Sanofi builds on immunology alliance with Regeneron for $1B upfront Exclusive: After Novo obesity deal, Kallyope rebrands and gets $94M for migraine trials Boehringer's weight loss candidate trails rivals in diabetes and obesity Top House advocates for psychedelics hear mixed opinions on provider credentialing CMS finalizes GLOBE rule as projected Medicare savings fall from $11.9B to $440M

Oct 08 11:00 am ET Site-central discordance in oncology trial imaging: New benchmarks and management strategies sponsored by Perceptive Imaging Oct 13 11:00 am ET Commercial excellence and AI - a ripple, wave or a tsunami sponsored by ZS Oct 15 1:00 pm ET Insights into Polycystic Kidney Disease: The Potential of Clinicogenomic Data sponsored by Natera Oct 20 11:00 am ET Intelligent oversight and orchestration: How mission control is redefining R&D decision-making sponsored by ZS Oct 21 11:00 am ET From prediction to decision: Digital twins and predictive modeling in clinical development sponsored by Flatiron Oct 22 11:00 am ET A new model for clinical research – Expanding community trial access sponsored by Parexel Oct 28 10:30 am ET The evolution of MRD: From molecular detection to clinical decisions sponsored by ABBOTT

Vice President, Regulatory Affairs Hinge Bio, Inc. Redwood City, CA, USA Team Leader, Analytical Research & Development (ARD) Veranova Devens, MA 01434, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

Twenty new honorees join the 140-plus women Endpoints News has recognized for reshaping biopharma. How did they get there, and what's changed? Join us for exclusive interviews, in-depth profiles and a frank look at gender representation in the industry today. Register now.

Endpoints Pharma Patient death raises liver questions ahead of Bristol Myers readout New biotech alliance tells Congress to fight for US dominance Lilly's amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes

in case you missed it 1. Varda gets $251M to make medicines in space, a long-sought area for drugs